USD 17.26
(-0.4%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 21.25 Billion GBP | 7.5% |
2022 | 19.77 Billion GBP | -12.18% |
2021 | 22.51 Billion GBP | 0.52% |
2020 | 22.39 Billion GBP | 2.3% |
2019 | 21.89 Billion GBP | 6.37% |
2018 | 20.58 Billion GBP | 3.71% |
2017 | 19.84 Billion GBP | 6.69% |
2016 | 18.59 Billion GBP | 23.42% |
2015 | 15.07 Billion GBP | -3.91% |
2014 | 15.68 Billion GBP | -12.48% |
2013 | 17.92 Billion GBP | -3.33% |
2012 | 18.53 Billion GBP | -7.57% |
2011 | 20.05 Billion GBP | -3.58% |
2010 | 20.8 Billion GBP | -0.9% |
2009 | 20.98 Billion GBP | 17.01% |
2008 | 17.93 Billion GBP | 2.44% |
2007 | 17.51 Billion GBP | -3.87% |
2006 | 18.21 Billion GBP | 7.81% |
2005 | 16.89 Billion GBP | 8.13% |
2004 | 15.62 Billion GBP | -7.52% |
2003 | 16.89 Billion GBP | 1.77% |
2002 | 16.6 Billion GBP | 3.16% |
2001 | 16.09 Billion GBP | 14.01% |
2000 | 14.11 Billion GBP | 239.68% |
1999 | 4.15 Billion GBP | -35.45% |
1998 | 6.43 Billion GBP | -19.32% |
1997 | 7.98 Billion GBP | -4.33% |
1996 | 8.34 Billion GBP | -20.49% |
1995 | 10.49 Billion GBP | 85.47% |
1994 | 5.65 Billion GBP | 14.73% |
1993 | 4.93 Billion GBP | 20.36% |
1992 | 4.09 Billion GBP | 20.58% |
1991 | 3.39 Billion GBP | 6.86% |
1990 | 3.17 Billion GBP | 23.7% |
1989 | 2.57 Billion GBP | 24.82% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 5.8 Billion GBP | 6.95% |
2024 Q1 | 5.42 Billion GBP | -5.04% |
2024 Q3 | 5.61 Billion GBP | -3.24% |
2023 FY | 21.25 Billion GBP | 7.5% |
2023 Q4 | 5.71 Billion GBP | -2.74% |
2023 Q1 | 5 Billion GBP | -2.53% |
2023 Q2 | 5.24 Billion GBP | 4.75% |
2023 Q3 | 5.87 Billion GBP | 11.99% |
2022 Q3 | 5.4 Billion GBP | 13.74% |
2022 Q1 | 6.09 Billion GBP | 4.16% |
2022 Q2 | 4.75 Billion GBP | -21.95% |
2022 FY | 19.77 Billion GBP | -12.18% |
2022 Q4 | 5.13 Billion GBP | -4.96% |
2021 Q1 | 4.93 Billion GBP | -11.31% |
2021 Q4 | 5.84 Billion GBP | -5.51% |
2021 Q3 | 6.18 Billion GBP | 11.74% |
2021 Q2 | 5.53 Billion GBP | 12.15% |
2021 FY | 22.51 Billion GBP | 0.52% |
2020 FY | 22.39 Billion GBP | 2.3% |
2020 Q4 | 5.56 Billion GBP | -3.35% |
2020 Q1 | 5.89 Billion GBP | 4.25% |
2020 Q3 | 5.76 Billion GBP | 11.32% |
2020 Q2 | 5.17 Billion GBP | -12.15% |
2019 Q3 | 6.14 Billion GBP | 18.72% |
2019 Q1 | 4.92 Billion GBP | -6.9% |
2019 Q4 | 5.65 Billion GBP | -7.96% |
2019 Q2 | 5.17 Billion GBP | 4.95% |
2019 FY | 21.89 Billion GBP | 6.37% |
2018 Q4 | 5.29 Billion GBP | -2.99% |
2018 Q2 | 5 Billion GBP | 3.5% |
2018 Q1 | 4.83 Billion GBP | -4.92% |
2018 FY | 20.58 Billion GBP | 3.71% |
2018 Q3 | 5.45 Billion GBP | 9.12% |
2017 Q1 | 4.87 Billion GBP | -4.08% |
2017 Q3 | 5.19 Billion GBP | 10.42% |
2017 Q2 | 4.7 Billion GBP | -3.49% |
2017 FY | 19.84 Billion GBP | 6.69% |
2017 Q4 | 5.08 Billion GBP | -2.12% |
2016 Q1 | 4.09 Billion GBP | 9.37% |
2016 Q2 | 4.4 Billion GBP | 7.62% |
2016 FY | 18.59 Billion GBP | 23.42% |
2016 Q3 | 5.01 Billion GBP | 13.82% |
2016 Q4 | 5.07 Billion GBP | 1.22% |
2015 Q3 | 3.92 Billion GBP | 1.03% |
2015 Q2 | 3.88 Billion GBP | 10.34% |
2015 Q1 | 3.51 Billion GBP | -15.35% |
2015 Q4 | 3.74 Billion GBP | -4.54% |
2015 FY | 15.07 Billion GBP | -3.91% |
2014 Q3 | 3.81 Billion GBP | -0.57% |
2014 Q4 | 4.15 Billion GBP | 8.91% |
2014 Q2 | 3.83 Billion GBP | -0.8% |
2014 Q1 | 3.87 Billion GBP | -11.64% |
2014 FY | 15.68 Billion GBP | -12.48% |
2013 Q4 | 4.38 Billion GBP | -0.43% |
2013 Q3 | 4.39 Billion GBP | -5.32% |
2013 Q2 | 4.64 Billion GBP | 3.36% |
2013 Q1 | 4.49 Billion GBP | -6.18% |
2013 FY | 17.92 Billion GBP | -3.33% |
2012 FY | 18.53 Billion GBP | -7.57% |
2012 Q4 | 4.79 Billion GBP | 7.76% |
2012 Q3 | 4.44 Billion GBP | -0.54% |
2012 Q2 | 4.47 Billion GBP | -7.45% |
2012 Q1 | 4.83 Billion GBP | -4.98% |
2011 FY | 20.05 Billion GBP | -3.58% |
2011 Q2 | 5.07 Billion GBP | 5.97% |
2011 Q3 | 5.1 Billion GBP | 0.59% |
2011 Q1 | 4.79 Billion GBP | -6.45% |
2011 Q4 | 5.08 Billion GBP | -0.45% |
2010 FY | 20.8 Billion GBP | -0.9% |
2010 Q3 | 4.9 Billion GBP | -8.59% |
2010 Q4 | 5.12 Billion GBP | 4.34% |
2010 Q1 | 5.4 Billion GBP | -9.54% |
2010 Q2 | 5.36 Billion GBP | -0.68% |
2009 Q3 | 4.97 Billion GBP | -1.56% |
2009 FY | 20.98 Billion GBP | 17.01% |
2009 Q4 | 5.97 Billion GBP | 20.08% |
2009 Q1 | 4.98 Billion GBP | 0.5% |
2009 Q2 | 5.05 Billion GBP | 1.47% |
2008 FY | 17.93 Billion GBP | 2.44% |
2008 Q1 | 4.38 Billion GBP | -1.72% |
2008 Q4 | 4.95 Billion GBP | 15.49% |
2008 Q3 | 4.29 Billion GBP | -1.58% |
2008 Q2 | 4.36 Billion GBP | -0.59% |
2007 Q2 | 4.46 Billion GBP | 2.39% |
2007 Q1 | 4.35 Billion GBP | -3.32% |
2007 Q3 | 4.24 Billion GBP | -4.9% |
2007 FY | 17.51 Billion GBP | -3.87% |
2007 Q4 | 4.46 Billion GBP | 5.19% |
2006 Q2 | 4.6 Billion GBP | -1.61% |
2006 Q4 | 4.5 Billion GBP | 1.99% |
2006 Q1 | 4.67 Billion GBP | 1.61% |
2006 Q3 | 4.42 Billion GBP | -3.99% |
2006 FY | 18.21 Billion GBP | 7.81% |
2005 Q2 | 4.08 Billion GBP | 4.51% |
2005 Q3 | 4.28 Billion GBP | 4.94% |
2005 Q4 | 4.6 Billion GBP | 7.42% |
2005 FY | 16.89 Billion GBP | 8.13% |
2005 Q1 | 3.9 Billion GBP | -12.68% |
2004 FY | 15.62 Billion GBP | -7.52% |
2004 Q4 | 4.47 Billion GBP | 17.19% |
2004 Q2 | 3.92 Billion GBP | 2.8% |
2004 Q3 | 3.81 Billion GBP | -2.73% |
2004 Q1 | 3.82 Billion GBP | 368.51% |
2003 Q1 | 4.15 Billion GBP | -5.88% |
2003 FY | 16.89 Billion GBP | 1.77% |
2003 Q4 | 815.34 Million GBP | -89.32% |
2003 Q3 | 7.63 Billion GBP | 79.0% |
2003 Q2 | 4.26 Billion GBP | 2.68% |
2002 Q4 | 4.41 Billion GBP | 13.5% |
2002 Q1 | 3.99 Billion GBP | -11.82% |
2002 FY | 16.6 Billion GBP | 3.16% |
2002 Q2 | 4.3 Billion GBP | 7.81% |
2002 Q3 | 3.89 Billion GBP | -9.64% |
2001 Q4 | 4.52 Billion GBP | 17.8% |
2001 FY | 16.09 Billion GBP | 14.01% |
2001 Q1 | 3.71 Billion GBP | -4.62% |
2001 Q2 | 4.01 Billion GBP | 8.03% |
2001 Q3 | 3.84 Billion GBP | -4.14% |
2000 FY | 14.11 Billion GBP | 239.68% |
2000 Q1 | 3.22 Billion GBP | 41.52% |
2000 Q2 | 3.51 Billion GBP | 8.96% |
2000 Q3 | 3.48 Billion GBP | -0.8% |
2000 Q4 | 3.89 Billion GBP | 11.65% |
1999 Q3 | 2.27 Billion GBP | 30.62% |
1999 Q2 | 1.74 Billion GBP | -13.4% |
1999 FY | 4.15 Billion GBP | -35.45% |
1999 Q1 | 2.01 Billion GBP | -2.51% |
1999 Q4 | 2.27 Billion GBP | 0.13% |
1998 Q2 | 1.63 Billion GBP | -15.18% |
1998 Q1 | 1.93 Billion GBP | 5.0% |
1998 Q4 | 2.06 Billion GBP | 0.32% |
1998 FY | 6.43 Billion GBP | -19.32% |
1998 Q3 | 2.05 Billion GBP | 25.57% |
1997 Q4 | 1.83 Billion GBP | -8.13% |
1997 Q3 | 2 Billion GBP | -0.5% |
1997 Q2 | 2.01 Billion GBP | -1.58% |
1997 Q1 | 2.04 Billion GBP | -39.2% |
1997 FY | 7.98 Billion GBP | -4.33% |
1996 Q4 | 3.36 Billion GBP | 35.14% |
1996 Q3 | 2.48 Billion GBP | 19.0% |
1996 Q1 | 2.12 Billion GBP | 0.0% |
1996 FY | 8.34 Billion GBP | -20.49% |
1996 Q2 | 2.09 Billion GBP | -1.69% |
1995 FY | 10.49 Billion GBP | 85.47% |
1995 Q3 | 1.62 Billion GBP | -3.35% |
1995 Q2 | 1.68 Billion GBP | 5.53% |
1995 Q1 | 1.59 Billion GBP | -3.17% |
1994 FY | 5.65 Billion GBP | 14.73% |
1994 Q1 | 1.51 Billion GBP | 6.89% |
1994 Q2 | 1.31 Billion GBP | -13.57% |
1994 Q3 | 1.63 Billion GBP | 24.39% |
1994 Q4 | 1.65 Billion GBP | 1.03% |
1993 Q3 | 1.39 Billion GBP | 27.31% |
1993 Q2 | 1.09 Billion GBP | -27.5% |
1993 Q1 | 1.5 Billion GBP | 31.64% |
1993 FY | 4.93 Billion GBP | 20.36% |
1993 Q4 | 1.42 Billion GBP | 2.05% |
1992 Q3 | 977.28 Million GBP | 32.74% |
1992 Q4 | 1.14 Billion GBP | 17.3% |
1992 FY | 4.09 Billion GBP | 20.58% |
1992 Q1 | 1.11 Billion GBP | 7.51% |
1992 Q2 | 736.26 Million GBP | -34.26% |
1991 FY | 3.39 Billion GBP | 6.86% |
1991 Q1 | 793.32 Million GBP | 10.95% |
1991 Q4 | 1.04 Billion GBP | -6.3% |
1991 Q3 | 1.11 Billion GBP | 9.3% |
1991 Q2 | 1.01 Billion GBP | 28.2% |
1990 Q4 | 715 Million GBP | -2.76% |
1990 Q1 | 784.13 Million GBP | 4.18% |
1990 FY | 3.17 Billion GBP | 23.7% |
1990 Q2 | 924.24 Million GBP | 17.87% |
1990 Q3 | 735.3 Million GBP | -20.44% |
1989 Q3 | 743.77 Million GBP | -5.75% |
1989 Q2 | 789.11 Million GBP | 35.63% |
1989 Q1 | 581.8 Million GBP | 3.51% |
1989 FY | 2.57 Billion GBP | 24.82% |
1989 Q4 | 752.7 Million GBP | 1.2% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
AstraZeneca PLC | 34.69 Billion USD | 38.743% |
Bristol-Myers Squibb Company PFD CONV 2 | 34.31 Billion USD | 38.064% |
CSPC Pharmaceutical Group Limited | 30.13 Billion USD | 29.485% |
Clarus Therapeutics Holdings, Inc. | 11.23 Million USD | -189025.211% |
Novartis AG | 34.18 Billion USD | 37.838% |
PT Kalbe Farma Tbk. | 743.47 Million USD | -2758.476% |